THE EFFICASY OF VENLAFAXINE IN COMPARISON WITH PLACEBO IN THE TREATMENT OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AMIRI SH.; GHOREISHIZADEH M.A.; MOHAMMADZADEH S.; MALEK A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Psychiatry and Clinical Psychology Year:2010 | Volume:16 | Issue:3 (62) Page(s): 275-275

Download Full-Text

Persian Verion

View:

6,162

Download:

Cites:

Information Journal Paper

Title

THE EFFICASY OF VENLAFAXINE IN COMPARISON WITH PLACEBO IN THE TREATMENT OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Author(s)

AMIRI SH. | GHOREISHIZADEH M.A. | MOHAMMADZADEH S. | MALEK A. | Issue Writer Certificate

Keywords

TREATMENTQ2

VENLAFAXINEQ3

ADULT ATTENTION DEFICITQ2

HYPERACTIVITY DISORDERQ2

Abstract

Objectives: The prevalence of adult ADHD is estimated to be 2 to 4 percent, where hyperactive-impulsive symptoms are less obvious compared to the inattentive symptoms. This disorder can negatively affect the educational, social, and occupational activities of those who suffer from its symptoms. Considering the importance of problem and it’s TREATMENT, therapeutic effects of VENLAFAXINE in the disorder.was studied. Method: In a double-blind control trial study, adults with ADHD (N=44, age range=18-45 years) were randomly assigned to receive 6 weeks of TREATMENT with either VENLAFAXINE or placebo. Results: The study group consisted of 20 patients (11 were male and 9 were female) and the control group were 21 patients (13 were male and 8 were female). One patient in the study group discontinued TREATMENT within the first week because of agitation and anxiety. One patient in the study group and two patients in the placebo group failed to follow up. The mean age of patients was 30.30 ± 8.31 and 30.70 ± 8.4, years in the VENLAFAXINE and in the placebo group respectively. A significant improvement in all the subscales inattention, hyperactive-impulsive, totals and ADHD-index were observed with VENLAFAXINE (225 mg per day) after four weeks of TREATMENT. Common side effects in the study group were dry mouth, anorexia and drowsiness while they were headache, nausea and insomnia in the placebo group. Conclusions: VENLAFAXINE is an effective and low risk medication in a short term TREATMENT course for adult ADHD. At the end of sixth week of TREATMENT it improves inattention and hyperactivity symptoms while patients tolerated the therapeutic dose of 75 mg three times daily.

Cites

EXAMINING THE STATUS OF SPIRITUAL HEALTH AMONG STUDENTS AT THE AUTONOMOUS CAMPUS OF KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES IN 2016

References

No record.

Cite

APA: Copy

AMIRI, SH., GHOREISHIZADEH, M.A., MOHAMMADZADEH, S., & MALEK, A.. (2010). THE EFFICASY OF VENLAFAXINE IN COMPARISON WITH PLACEBO IN THE TREATMENT OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL. IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 16(3 (62)), 275-275. SID. https://sid.ir/paper/17054/en

Vancouver: Copy

AMIRI SH., GHOREISHIZADEH M.A., MOHAMMADZADEH S., MALEK A.. THE EFFICASY OF VENLAFAXINE IN COMPARISON WITH PLACEBO IN THE TREATMENT OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL. IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY[Internet]. 2010;16(3 (62)):275-275. Available from: https://sid.ir/paper/17054/en

IEEE: Copy

SH. AMIRI, M.A. GHOREISHIZADEH, S. MOHAMMADZADEH, and A. MALEK, “THE EFFICASY OF VENLAFAXINE IN COMPARISON WITH PLACEBO IN THE TREATMENT OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL,” IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, vol. 16, no. 3 (62), pp. 275–275, 2010, [Online]. Available: https://sid.ir/paper/17054/en

Related Journal Papers